P
Peter J. Little
Researcher at University of the Sunshine Coast
Publications - 285
Citations - 10251
Peter J. Little is an academic researcher from University of the Sunshine Coast. The author has contributed to research in topics: Vascular smooth muscle & Phosphorylation. The author has an hindex of 50, co-authored 269 publications receiving 8410 citations. Previous affiliations of Peter J. Little include Box Hill Hospital & Group Health Cooperative.
Papers
More filters
Journal ArticleDOI
The Nerve Growth Factor Signaling and Its Potential as Therapeutic Target for Glaucoma
Haitao Wang,Rikang Wang,Thilini Thrimawithana,Peter J. Little,Jiangping Xu,Zhong-Ping Feng,Wenhua Zheng +6 more
TL;DR: The current understanding of the NGF signaling in retina and the therapeutic implications in the treatment of glaucoma are discussed.
Journal ArticleDOI
FOXO Signaling Pathways as Therapeutic Targets in Cancer.
TL;DR: Therapeutically targeting the FOXO signaling pathway(s) could lead to the discovery of efficacious agents against some cancers, but this requires an enhanced understanding and knowledge of FOXO transcription factors and their regulation and functioning.
Journal ArticleDOI
Insulin resistance and atherosclerosis
TL;DR: This review addresses the metabolic consequences of the insulin resistance syndrome, its relationship with Atherosclerosis, and the impact of insulin resistance on processes of atherosclerosis including insulin signaling in cells of the vasculature.
Journal ArticleDOI
Cardiovascular actions and therapeutic potential of tanshinone IIA.
TL;DR: This review focuses on the protective effects and the mechanism of action of TS in the cardiovascular system, and provides a novel perspective on clinical use of TS.
Journal ArticleDOI
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
TL;DR: This review aims to integrate the current understanding of LOX-1 signaling, regulation of LOx-1 by vasculoprotective drugs, and the importance of LOZ-1 in the pathogenesis of atherosclerosis to suggest an attractive therapeutic target for the treatment of human atherosclerotic diseases.